Literature DB >> 7525299

Fas ligation triggers apoptosis in macrophages but not endothelial cells.

B C Richardson1, N D Lalwani, K J Johnson, R M Marks.   

Abstract

The reticuloendothelial system includes macrophages and endothelial cells. These cells are produced and destroyed in vivo with a precision that implies the existence of homeostatic mechanisms. The stimuli for endothelial cell proliferation and monocyte production are becoming well characterized. However, the mechanisms involved in eliminating these cells are poorly understood. One mechanism involved in cellular elimination is apoptosis, which can be triggered in some cells by ligation of the Fas molecule. In this report we have investigated whether macrophages and endothelial cells express the Fas molecule, and whether Fas transmits an apoptosis-inducing signal in these cells. We demonstrate that macrophages express Fas and readily undergo apoptosis when cultured with anti-Fas. In contrast, while endothelial cells can express the Fas molecule, Fas ligation is insufficient to induce apoptosis. These results suggest differential regulation of Fas function among cells of the reticuloendothelial system, and imply different mechanisms of homeostasis.

Mesh:

Substances:

Year:  1994        PMID: 7525299     DOI: 10.1002/eji.1830241111

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway.

Authors:  K Nakatani; S Takeshita; H Tsujimoto; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Soothing touch of CD31 protects endothelium during cellular immune responses.

Authors:  Olivier Thaunat
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

3.  Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.

Authors:  Mehmet H Kural; Juan Wang; Liqiong Gui; Yifan Yuan; Guangxin Li; Katherine L Leiby; Elias Quijano; George Tellides; W Mark Saltzman; Laura E Niklason
Journal:  Biomaterials       Date:  2019-05-07       Impact factor: 12.479

Review 4.  Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?

Authors:  Muna Affara; Benjamin Dunmore; Christopher Savoie; Seiya Imoto; Yoshinori Tamada; Hiromitsu Araki; D Stephen Charnock-Jones; Satoru Miyano; Cristin Print
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

5.  The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.

Authors:  A Bordron; M Dueymes; Y Levy; C Jamin; J P Leroy; J C Piette; Y Shoenfeld; P Y Youinou
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Early immune responses accompanying human asymptomatic Ebola infections.

Authors:  E M Leroy; S Baize; P Debre; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

7.  Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts.

Authors:  C Dong; G L Winters; J E Wilson; B M McManus
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

Authors:  W C Liles; P A Kiener; J A Ledbetter; A Aruffo; S J Klebanoff
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  Fas-mediated apoptosis of neutrophils in sera of patients with infection.

Authors:  I E Nwakoby; K Reddy; P Patel; N Shah; S Sharma; M Bhaskaran; N Gibbons; A A Kapasi; P C Singhal
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

10.  Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

Authors:  D Ashany; X Song; E Lacy; J Nikolic-Zugic; S M Friedman; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.